⌘K

Login Start Free

Home/Filings/5/0001209191-13-001301

5//SEC Filing

Youssoufian Hagop 5

Accession 0001209191-13-001301

CIK 0001107421other

View on SEC.gov Company Profile

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 5:13 PM ET

Size

5.0 KB

Accession

0001209191-13-001301

Insider Transaction Report

Form 5

Period: 2012-12-31

ZIOPHARM ONCOLOGY INCZIOP

Youssoufian Hagop

Executive VP, CMO

Transactions

Tax Payment
Common Stock
2012-07-11$6.06/sh−15,740$95,384→ 99,640 total

Footnotes (1)

[F1]Disposition represents shares withheld to satisfy withholding tax obligations upon the vesting of a restricted stock grant.

Documents

1 file

5
doc5.xmlPrimary
FORM 5 SUBMISSION

Issuer

ZIOPHARM ONCOLOGY INC

CIK 0001107421

Entity typeother

Related Parties

1

filerCIK 0001525899

Filing Metadata

Form type: 5
Filed: Jan 2, 7:00 PM ET
Accepted: Jan 3, 5:13 PM ET
Size: 5.0 KB

View on SEC.gov